Literature DB >> 15380119

Verbal memory decline and adverse effects on cognition in adult patients with pharmacoresistant partial epilepsy: a longitudinal controlled study of 36 patients.

Lena Andersson-Roswall1, Elisabeth Engman, Hans Samuelsson, Charlotte Sjöberg-Larsson, Kristina Malmgren.   

Abstract

The aim of this study was to delineate possible longitudinal cognitive changes in adult patients with a long history of pharmacoresistant partial epilepsy. Thirty-six patients and thirty healthy controls were investigated at baseline. A reassessment was conducted, with median test intervals of 4.8 years for the patients and 3.1 years for controls. A standardized battery was used for assessment of general cognitive level and memory. At baseline, patients performed at a significantly lower level on general cognition, immediate recall of pairs of associated words, and retention of learned words and visuospatial stimuli, compared with controls. Analyses of change over time in the patients disclosed significant verbal memory decline in retention of pairs of associated words. Group comparisons of change over time revealed adverse effects in the performance aspect of general cognition on the patients. Also, group comparisons indicated impaired performance across time for the patients in retention of pairs of associated words and retention of visuospatial stimuli. The adverse effect on memory and general cognition in this patient group over the period was clear-cut when compared with the longitudinal changes in an adequate control group.

Entities:  

Mesh:

Year:  2004        PMID: 15380119     DOI: 10.1016/j.yebeh.2004.05.012

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  4 in total

1.  Do seizures harm the brain?

Authors:  Donna C Bergen
Journal:  Epilepsy Curr       Date:  2006 Jul-Aug       Impact factor: 7.500

2.  Growing older with drug-resistant epilepsy: cognitive and psychosocial outcomes.

Authors:  Rani A Sarkis; Scott McGinnis; Sara N Rushia; Suna Park; Emile E Ansari; Kim C Willment
Journal:  J Neurol       Date:  2018-02-24       Impact factor: 4.849

Review 3.  Cognitive progression in epilepsy.

Authors:  Michael Seidenberg; Dalin T Pulsipher; Bruce Hermann
Journal:  Neuropsychol Rev       Date:  2007-11-08       Impact factor: 6.940

4.  NRSF and BDNF polymorphisms as biomarkers of cognitive dysfunction in adults with newly diagnosed epilepsy.

Authors:  Alix Warburton; Fabio Miyajima; Kanvel Shazadi; Joanne Crossley; Michael R Johnson; Anthony G Marson; Gus A Baker; John P Quinn; Graeme J Sills
Journal:  Epilepsy Behav       Date:  2015-12-17       Impact factor: 2.937

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.